Abiopharma

Can-Fite’s CF602 Erectile Dysfunction Treatment Receives Notice of Patent Allowance in Brazil

Gain Therapeutics Presents Preclinical GT-02287 Data at Neuroscience 2025

SciSparc Notification (SPRC)

SciSparc: Neurothera Labs Announces Israeli Patent Application in Collaboration with Clearmind Medicine for Novel Non-Hallucinogenic Neuroplastogen Treatment for Depression

Compass Pathways - Compass Pathways to Participate in Two Investor Conferences in December

Compass Pathways to Participate in Two Investor Conferences in December

Clearmind Medicine Accelerate FDA-Approved Alcohol Use Disorder Clinical Trial by Activating Fifth Elite Global Medical Site

RadNet’s DeepHealth Announces Wichita Radiological Group as First Operations Suite™ Customer

Alvotech and Advanz Pharma Receive Marketing Approval Across the European Economic Area for Gobivaz®, a First-in-Market Biosimilar to Simponi® (golimumab)

Alvotech and Advanz Pharma Receive Marketing Approval Across the European Economic Area for Gobivaz®, a First-in-Market Biosimilar to Simponi® (golimumab)